- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Zydus Lifesciences Limited — Updates, 12-02-2026: General Updates
12-02-2026 | 08:26 am
12-02-2026 | 08:26 am
Zydus settled US patent litigation with Astellas over generic Mirabegron. This agreement includes a $120 million (~₹996 Cr) payment and a licensing fee until Sept 2027, enabling Zydus to continue marketing the drug in the US.
No comments yet. Be the first to comment!